Search Results - Phuoc VH
- Showing 1 - 1 results of 1
-
1
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma by Jain MD, Bachmeier CA, Phuoc VH, Chavez JC
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book